|

The 5-FU Holter Study

RECRUITINGN/ASponsored by University of Auckland, New Zealand
Actively Recruiting
PhaseN/A
SponsorUniversity of Auckland, New Zealand
Started2024-11-01
Est. completion2025-07
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06538610

Summary

To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients with diagnosis of gastrointestinal malignancy
* Planned to receive either FOLFOX chemotherapy with any treatment intent
* Aged ≥ 18 years at time of signing informed consent form

Exclusion Criteria:

• ECG with left bundle branch block or left ventricular hypertrophy with strain

Conditions2

CancerGastrointestinal Malignancy

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.